Study of the effect of antimicrobial peptide mimic, CSA‐13, on an established biofilm formed by Pseudomonas aeruginosa
Open Access
- 25 February 2013
- journal article
- research article
- Published by Wiley in Microbiologyopen
- Vol. 2 (2) , 318-325
Abstract
The formation of a Pseudomonas aeruginosa biofilm, a complex structure enclosing bacterial cells in an extracellular polymeric matrix, is responsible for persistent infections in cystic fibrosis patients leading to a high rate of morbidity and mortality. The protective environment created by the tridimensional structure reduces the susceptibility of the bacteria to conventional antibiotherapy. Cationic steroid antibiotics (CSA)‐13, a nonpeptide mimic of antimicrobial peptides with antibacterial activity on planktonic cultures, was evaluated for its ability to interact with sessile cells. Using confocal laser scanning microscopy, we demonstrated that the drug damaged bacteria within an established biofilm showing that penetration did not limit the activity of this antimicrobial agent against a biofilm. When biofilms were grown during exposure to shear forces and to a continuous medium flow allowing the development of robust structures with a complex architecture, CSA‐13 reached the bacteria entrapped in the biofilm within 30 min. The permeabilizing effect of CSA‐13 could be associated with the death of the bacteria. In static conditions, the compound did not perturb the architecture of the biofilm. This study confirms the potential of CSA‐13 as a new strategy to combat persistent infections involving biofilms formed by P. aeruginosa.Keywords
Funding Information
- Fonds National de la Recherche Scientifique (3457710)
- Center for Biofilm Engineering in Bozeman
This publication has 32 references indexed in Scilit:
- Identification of Peptides Derived from the Human Antimicrobial Peptide LL-37 Active against Biofilms Formed by Pseudomonas aeruginosa Using a Library of Truncated FragmentsAntimicrobial Agents and Chemotherapy, 2012
- Clinical Significance of Microbial Infection and Adaptation in Cystic FibrosisClinical Microbiology Reviews, 2011
- Spotlight on Human LL-37, an Immunomodulatory Peptide with Promising Cell-Penetrating PropertiesPharmaceuticals, 2010
- Spatial and Temporal Patterns of Biocide Action against Staphylococcus epidermidis BiofilmsAntimicrobial Agents and Chemotherapy, 2010
- Extracellular DNA: A Major Proinflammatory Component of Pseudomonas aeruginosa BiofilmsThe Journal of Immunology, 2010
- N-acetylcysteine inhibit biofilms produced by Pseudomonas aeruginosaBMC Microbiology, 2010
- Improvements in Lung Function Outcomes in Children with Cystic Fibrosis are Associated with Better Nutrition, Fewer Chronic Pseudomonas aeruginosa Infections, and Dornase Alfa UseThe Journal of Pediatrics, 2008
- ATP hydrolysis-driven gating in cystic fibrosis transmembrane conductance regulatorPhilosophical Transactions of the Royal Society B: Biological Sciences, 2008
- Cystic fibrosis mortality and survival in the UK: 1947–2003European Respiratory Journal, 2006
- Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2006